Protein kinase C modulators. K.

Details Protein kinase C modulators. K. Protein kinase C modulators. K.

1993-09-13

1997-07-01

Barts, Samuel

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514548, 514552, 514544, 514662, 556427, 554110, 554228, 554223, 554226, 554101, 554 78, 554 91, 560 83, 560256, 560194, 560102, 560107, A61K 31235

Patent

active

056439482

ABSTRACT:
Compounds having anti-inflammatory and other activities are disclosed. The compounds are derived from diterpenes of the phorbol-, resiniferonol- and ingenol-classes.

REFERENCES:
patent: 4376821 (1983-03-01), Braude
patent: 4376822 (1983-03-01), Braude
patent: 4401756 (1983-08-01), Gillis
patent: 4460685 (1984-07-01), Vilcek et al.
Chem. Abstracts 103:136912 1984.
Chem Abstracts 103:136798 1985.
Marshall, G.T. et al., "Short-Chain Phorbol Ester Constituents of Croton Oil," JAOCS, 61(7): 1220-1225 (Jul. 1984).
Paquette, L.A. et al., "Ingenane Sythetic Studies. An Expedient Approach to Highly Oxygenated ABC Subunits of Ingenol via Reductive Dialkylative Annulation and .alpha.,.beta.-Epoxy Ketone Photoisomerization" J. Am. Chem. Soc. 106: 1446-1454 (1984).
Ross, R.J. et al., "Ingenane Synthetic Studies. Stereocontrolled Introduction of All Oxygenated Unsaturated Centers in an Ingenol Prototype," J. Org. Chem. 52: 5497-5498 (1987).
Uemura, D. et al., "Isolation and Structures of Irritant Substances Obtained from Euphorbia Species "(Euphorbiaceae) Tetrahedron Letters 11: 881-884 (1973).
J. Med Chem. 1992, 35, 3792-3802, Saari et al.
Antiviral Agents Bulletin, vol. 6 No. 6, Jun. 1993.
Antiviral Agents Bulletin, vol. 6 No. 8, Aug. 1993.
Letter form Dr. Sandstrom, Jun. 19, 1990.
Antimicrobial Agents and Chemotherapy, Feb. 1992, pp. 245-254, Connolly et al.
Anti-HIV therapy: A lesson in drug design, Mansuri (1992).
AIDS Research and Human Retrovirus, vol. 8, No. 2, pp. 119-124, 1192, DeClercq Merck Standby Statement of Sep. 14, 1993.
J.A. Dunn and P.M. Blumberg, Cancer Res., 43: 4632-4637, (1983).
T. Sugimura, Gann 73: 499-507, (1982).
Y. Endo et al., Chem. Pharm. Bull. 32: 358-261, (1984).
E. Hecker and R. Schmidt, Fortschritte D. Chemie Organischer Naturstoffe 31: 377-467, (1974).
F.J. Evans and C.J. Soper, Lloydia 41: 193-233, (1978).
R. Schmidt and E. Hecker, Aktuelle Problems aus dem Gebiet der Cancerologie III, pp. 98-108, (1971).
H.W. Thielmann, et al., Forschritte der Krebsforschung, vol. VII, pp. 171-179, New York: Schattauer, (1969).
E. Hecker, Carcinogenesis, vol. II. Mechanisms of Tumor Promotion and Carcinogenesis, pp. 11-48. New York: Raven Press, (1978).
Y. Nishizuka, Nature 308:693-698, (1984).
Y. Nishizuka, Science 225: 1365-1370, (1984).
P. Driedger and P. Blumberg, Cancer Research 39: 714-719, (1979).
P. Driedger and P.M. Blumberg, Cancer Research 37: 3257-3265, (1977).
B. Ganong et al., Proc. Natl. Acad. Sci. 83: 1184-1188, (1986).
R. Schmidt and E. Hecker, Carcinogenesis 7: 57-63, (1982).
K. Irie, et al., Int. J. Cancer 36: 485-488, (1985).

Affiliated with

Also associated with

Rating

Protein kinase C modulators. K. does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein kinase C modulators. K., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase C modulators. K. will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-597683